BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 36222034)

  • 1. [Association between regional fat mass and risk of nonalcoholic fatty liver disease in overweight/obese adults].
    Zeng Y; Yuan S; Xie M; Xiao T; Huang Z; Zhou J; He Q; Yang Y; Ma J
    Wei Sheng Yan Jiu; 2022 Sep; 51(5):753-760. PubMed ID: 36222034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in the associations between adiposity distribution and cardiometabolic risk factors in overweight or obese individuals: a cross-sectional study.
    Yang Y; Xie M; Yuan S; Zeng Y; Dong Y; Wang Z; Xiao Q; Dong B; Ma J; Hu J
    BMC Public Health; 2021 Jun; 21(1):1232. PubMed ID: 34174845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
    Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
    Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study.
    Yu C; He S; Kuang M; Wang C; Huang X; Sheng G; Zou Y
    BMC Endocr Disord; 2024 Feb; 24(1):22. PubMed ID: 38369482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
    Shao C; Ye J; Li F; Feng S; Wang W; Zhong B
    Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
    Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
    J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Effect of Body Mass Index and Waist Circumference in Predicting Nonalcoholic Fatty Liver Disease.
    Lee HL; Baik SJ; Cho WJ; Son DH; Lee YJ
    Metab Syndr Relat Disord; 2023 Nov; 21(9):497-502. PubMed ID: 37669452
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of the android to gynoid fat ratio with nonalcoholic fatty liver disease: a cross-sectional study.
    Yang L; Huang H; Liu Z; Ruan J; Xu C
    Front Nutr; 2023; 10():1162079. PubMed ID: 37255941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
    Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
    Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study.
    Zhang J; Li K; Pan L; Teng F; Zhang P; Lin B; Yuan Y; Wei X; Li W; Zhang H
    BMC Gastroenterol; 2021 Mar; 21(1):131. PubMed ID: 33743586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between weight change, waist circumference change, and the risk of nonalcoholic fatty liver disease in individuals with metabolically healthy overweight or obesity and metabolically unhealthy overweight or obesity.
    Man S; Deng Y; Ma Y; Yang X; Wang X; Fu J; Yu C; Lv J; Du J; Wang B; Li L
    Obes Res Clin Pract; 2024; 18(2):109-117. PubMed ID: 38443283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of sex-specific body mass index and waist circumference trajectories with non-alcoholic fatty liver disease incidence based on growth mixture modeling.
    Cao T; Tong C; Li Q; Han Y; Halengbieke A; Ni X; Gao B; Zheng D; Yang X
    Nutr Metab Cardiovasc Dis; 2024 May; 34(5):1245-1256. PubMed ID: 38342721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglycerides Mediate the Influence of Body Mass Index on Non-Alcoholic Fatty Liver Disease in a Non-Obese Chinese Population with Normal Low-Density Lipoprotein Cholesterol Levels.
    Han X; Kong J; Zhang H; Zhao Y; Zheng Y; Wei C
    Obes Facts; 2024; 17(2):191-200. PubMed ID: 38266508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of non-alcoholic fatty liver disease with total testosterone in non-overweight/obese men with type 2 diabetes mellitus.
    Yang LJ; Zhou JZ; Zheng YF; Hu X; He ZY; Du LJ; Gu X; Huang XY; Li J; Li YQ; Pan LY; Zhang XX; Gu XJ
    J Endocrinol Invest; 2023 Aug; 46(8):1565-1572. PubMed ID: 36725809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study.
    Ahmed OT; Gidener T; Mara KC; Larson JJ; Therneau TM; Allen AM
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1374-1381.e6. PubMed ID: 34265444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the relationship between indexes of different abnormal weight and dyslipidemia in adults in Beijing City].
    Ma AJ; Dong Z; Qi K; Jiang B; Xie C
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Mar; 57(3):400-405. PubMed ID: 36922174
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.